loader image
Friday, February 13, 2026
80.3 F
McAllen
- Advertisement -

Taking Blood Thinners After a Stroke Does Not Improve Outcomes, Study Says

Translate to Spanish or other 102 languages!

Adding blood thinners to clot-busting medication after a stroke does not appear to improve the outcomes, according to a new study. Image for illustration purposes
Adding blood thinners to clot-busting medication after a stroke does not appear to improve the outcomes, according to a new study. Image for illustration purposes
- Advertisement -
  • About 15 million people around the world have a stroke each year, with about 62% of cases being ischemic strokes. 
  • The main treatment for ischemic stroke is a clot-busting medication delivered within 3 hours of having a stroke. 
  • After a stroke, a doctor may prescribe blood-thinning medications to help prevent clots from forming again. 
  • Researchers from the Washington University School of Medicine in St. Louis, MO, have found that giving blood thinners in conjunction with clot-busting medications when a person has an ischemic stroke did not improve the person’s 90-day outcome.

Researchers report that about 15 million people around the world have a stroke in the course of a year. About 62%Trusted Source of those people will have an ischemic stroke where blood flow to the brain is stopped due to arterial blockages.

Follow the link below to Medical News Today to read the full story:

https://www.medicalnewstoday.com/articles/taking-blood-thinners-after-a-stroke-does-not-improve-outcomes-study-says?utm_source=Sailthru%20Email&utm_medium=Email&utm_campaign=MNT%20Daily%20News&utm_content=2024-02-15&apid=&rvid=4ba4ec80177cae00eabc43b8bc6648d598c4a356d104663735777e0a0f8b5c9f

- Advertisement -

Information Source: https://www.medicalnewstoday.com

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

Breakthrough TTFields Technology Gets FDA Approval for Pancreatic Cancer Treatment

Mega Doctor News The U.S. Food and Drug Administration has approved a...

El Paso Researchers Advance New Treatments for Cancer and Heart Disease

Ramadevi Subramani Reddy, Ph.D., remembers the neem tree from her childhood in India — a plant her grandmother used to treat everything from fevers to infections.

Researchers Identify Ancestry‑Specific Risk Factors for IBD in Hispanic Populations

Hispanic patients with inflammatory bowel disease (IBD) can experience very different disease patterns depending on whether they have higher African or Amerindian genetic ancestry, according to a large multicenter study led by Cedars-Sinai.

Unexpected Cancer Drug Combo Shows Stronger Results Against Ovarian Tumors

A new study published by Mayo Clinic researchers suggests that ovarian cancer cells quickly activate a survival response after PARP inhibitor treatment, and blocking this early response may make this class of drugs work better.
- Advertisement -
×